NDC 0169-6339 – Novolog

Insulin Aspart 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug 2 recalls

Product NDC0169-6339

Product details

Brand name
Novolog
Generic name
Insulin aspart
Labeler
Novo Nordisk
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
BLA · BLA020986
Marketed since
January 22, 2003
Listing expires
December 31, 2026
Pharmacologic class
Insulin Analog

Active ingredients

Uses, dosage, side effects and warnings for Novolog →

Package NDC codes (2)

Package NDCDescriptionSince
0169-6339-105 SYRINGE, PLASTIC in 1 CARTON (0169-6339-10) / 3 mL in 1 SYRINGE, PLASTICJan 22, 2003
0169-6339-98 sample1 SYRINGE, PLASTIC in 1 CARTON (0169-6339-98) / 3 mL in 1 SYRINGE, PLASTIC (0169-6339-90)Jan 22, 2003

Recalls mentioning this NDC

Other Novolog products